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Paris, France (V.M.-T., M l . ) ;  Department o f  Immunohematology, Central
Laboratory o f the Netherlands Red Cross Blood Transfusion Service fF.HJ, and Division  o f 
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The human promyelocytic cell line NB4 exhibited a weak adhesion capacity for 
bone marrow-derived stromal cells and their extracellular matrices (5-15% of 
adherent ceils). Adhesion was enhanced by pulse-treatment of cells with phorbol- 
ester (PMA 10~7 M). Adhesion was induced within minutes, was fibronectin- 
specific, and affected up to 100% of the treated cells. This biological response to 
PMA resulted from the activation of protein kinase C (PKC), since PKC inhibitors 
(staurosporine, sphingosine, CGP 41251, and calphostin C) prevented the phe­
nomenon. Phenotypical analysis of integrin receptor expression (particularly FN 
receptors VLA-4 and VLA-5) at the membrane of untreated or PMA-treated cells 
revealed that PMA induced no significant modification of the level of expression 
of these receptors. However, inhibition studies carried out w ith anti-VLA mono­
clonal antibodies demonstrated that the FN-specific adhesion triggered by PKC 
involved the a5(31 FN-specific receptors (VLA-5). We showed that the binding of 
NB4 cells to fibronectin was RGD-dependent. PMA-induced adhesion was not 
correlated to phosphorylation of the VLA-5 receptor. These findings may partially 
explain the malignant behaviour of these cells: The loss of their capacity to adhere 
to stromal cells may arrest differentiation and explain the large number of leuke­
mic cells in the circulation. © 1992 Wiley-Liss, Inc.
The cellular microenvironment plays a critical role 
in the development of the hematopoietic moiety of the 
marrow by the production of soluble factors and an 
extracellular matrice (ECM) (Dexter et al., 1977a,b; 
Tavassoli and Takahashi, 1982; Kamenov and Longe- 
necker, 1985; reviewed by Torok-Storb, 1988). Roles for 
ECM in the regulation of proliferation, differentiation, 
and cell migration have been described in the develop­
ment of a great number of tissues (Thiery et al., 1989). 
In marrow, it has been proposed th a t ECM contributes 
to cell survival» cell renewal, and cell egress as well as 
the expression of specific cell function by binding regu­
latory molecules (Gordon et al., 1988). Fibronectin 
(FN), hemonectin, collagens, and laminins are mole­
cules that promote growth, differentiation, anchoring, 
spreading, and migration of hemopoietic cells. The in­
teractions between hematopoietic cells and ECM com­
ponents are mediated by specific receptors th a t associ- 
ate a common p subunit (pi, (32, or p3) to different a 
chains and belong to the integrin family (Hynes, 1987). 
Among these integrins present on many hemopoietic 
cells, the a4p i and c¿5pi FN receptors (Euoslahti, 1988; 
Hemler, 1990; Hynes, 1990) have potentialy important 
roles in ECM-dependent progenitor cell differentiation
© 1992 W ILEY -LISS, INC.
and maturation. The expression of adhesion molecules 
is correlated to the capacity of progenitor cells to inter­
act with stromal cells and varies according to their 
lineage and/or their stage of differentiation (Coulombel 
et aL, 1988), including alterations related to malig­
nancy (Caligaris-Cappio et al., 1989).
Hemopoietic cells a t the immature stages of develop­
m ent are confined to the marrow tissue in close associ­
ation with stromal cells. This feature is verified in Dex­
te r cultures (Dexter et al., 1977a) where these cells are 
preferentially nested in the hemopoietic foci of the ad­
herent stromal cell layer. In vivo a massive marrow 
egress of immature blasts and promyelocytic cells is 
indeed observed in some pathological conditions, and 
particularly in leukemia. The lack of interaction of leu­
kemic cells with stromal cells might be due to some 
constitutive or functional defects in the adhesion effec­
tor system. Numerous reports have proposed tha t re-
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ceptor-mediated cell adhesion is regulated by protein 
kinases (Hirst et al., 1986) and, obviously, linking the 
loss of ECM adhesion of leukemic cells to both a charac­
terized intracellular signal pathway and a membrane 
adhesion receptor complex should help to define the 
defect of leukemic cells.
The NB4 cell line, the first human promyelocytic 
leukemia cell line (M3) (Lanotte et aL, 1991) with the 
specific t(15;17) chromosomal translocation (de Thé 
et al,, 1990) furnished a unique in vitro model for cellu­
lar and molecular studies. In th is work, we demonstrate 
that NB4 cells, only a minor proportion of which bound 
to stromal cell ECM or fibronectin, were rapidly in­
duced to adhere in response to PMA. We show that 
adhesion of NB4 cells to FN was mediated by the a5(31 
integrin receptor and required PKC activation.
MATERIALS AND METHODS 
Chemicals and reagents
Fibronectin was purified from human plasma 
(Sigma-Chimie or IMEDEX, Lyon, France). Collagens 
(I, III, IV, and V), laminin, staurosporine, sphingosine, 
PMA, PDBu, PMA-methyl-ether, phorbol, 4a-phorbol, 
A 23187, PGEi, PGE2) PGFi a , PGF2a, PGA1} PGD2, 
IBMX, isoproterenol, 8-CPT-cAMP, 8-Cl-cAMP, W7, 
RGDS, and RGES peptides were all purchased from 
Sigma, Phorbols were prepared as 2 mM stock solutions 
in dimethylsulfoxyde (DMSO) and diluted in RPMI be­
fore each experiment. Cholera toxin (CT) was furnished 
by the Institut Mérieux. (Lyon, France), CGP 41251 
was given by Ciba-Geigy (Basel, Switzerland). Calphos- 
tin C and microcystin were gifts from S,0. Doskeland 
(Bergen, Norway). Calphostin C was photoactivated by 
fluorescent light as described by Bruns et al, (1991)* 
Monoclonal antibodies (MoAbs) against (31(K20), a.2 
(GI9), a4 (HP2/1), a5 (SAMI), and a 6 (GoH3) chains of 
integrins were provided by Immunotech (Luminy, 
France). AIIB2 anti-pl rat monoclonal antibody was 
used for inhibition of adhesion studies, Ultroser HY 
medium supplement was furnished by IBF (France) 
and BCA reagents by Pierce (Netherlands).
Cell culture and cell treatment with PMA
The promyelocytic cell line NB4 (Lanotte et al., 1991) 
was grown in RPMI medium with 1% (v/v) Ultroser 
HY, in a humidified 5% C 02/air incubator, a t 37°C. 
Exponential cell growth was obtained by culturing cells 
between 5.104 and 5.10s cells per ml. The doubling time 
was 48 h. Cells were washed in RPMI medium and 
incubated in culture medium (106/ml) with PMA (10-7 
M) for 60 min at 37°C. Cells were then washed twice 
before analysis,
Adhesion to human stromal cells and their 
extracellular matrices
Stromal cells were obtained by trypsinization of the 
adherent layer derived from normal hum an bone m ar­
row cell culture (Lanotte et al., 1981). Stromal cells 
were cultured in 24-well plates (3.104/well) for 7 days at 
37°C, until they became confluent. Cultures were then 
washed three times in serum-free RPMI medium before 
the adhesion assay.
ECM were prepared from confluent stromal cell cul­
tures in 24-well plates. Cells were washed once in phos­
phate-buffered saline (PBS) then, 0.5 ml aliquots of
0.5% (w/v) Triton X 100 in PBS were added to each well 
as described by Vlodawsky et al. (1980), Plates were 
incubated under slow agitation for 1 h at room temper­
ature. Wells were then washed five times with PBS 
before use.
NB4 cells (2.105/ml) were incubated with 1 fxCi/ml of 
125I-5-Iododeoxyuridine (sp. act. 2,000 Ci/mmol; Amer- 
sham-France) for 4 h at 37°C. They were then washed 
three times in RPMI and resuspended at 1.6 x 108/ml 
in RPMI supplemented with 1% Ultroser HY and 1% 
BSA, with or without 10' 7 M PMA. In each well, 300 jjlI 
aliquots of radiolabeled-cell suspensions were added 
containing either stromal cells or ECM and incubated 
for 2 h at 37°C, Radioactivity in each well, evaluated 
using a gamma counter (LKB), represented the total 
cpm. Nonadherent cells were discarded and wells were 
washed three times with RPMI medium. Adherent cells 
were solubilized with a 0.5 M NaOH, 1% SDS solution 
and counted.
Adhesion assay to coated surfaces
Culture plate wells (96 well plates) were coated for 
3-4 h at 37°C with 50 fxl of PBS containing 50 fxg/ml of
either human fibronectin or other substrata (bovine 
serum albumin, BSA; human laminin; human colla­
gens). Wells were then washed with PBS and 200 \A of a 
3% (w/v) BSA solution was added to each well to satu­
rate nonspecific adsorption sites on the plastic surface. 
Plates were incubated for 1 h at 37°C then washed three 
times in PBS.
Exponentially growing NB4 cells were pelleted, 
washed once in fresh medium, and resuspended at 10 
cells/ml, in medium supplemented with Ultroser HY, 
To each well were added 100 [xl aliquots of cell suspen­
sion; cells were allowed to adhere to the substrata for 2 
h at 37°C. Unattached cells were subsequently removed 
by washing three times with PBS. Adherence of cells 
was quantified according to the method of Tuszinski 
and Murphy (1990), based on the colorimetric evalua­
tion of cellular proteins in each well. Briefly, 200 fxl of 
bicinchoninic acid (BCA) reagent were added to each 
well and the plates were incubated for 30 min at 60°C. 
The optical density was then read at 570 nm.
To determine the inhibition of adhesion to fibronec­
tin, NB4 cells were preincubated in suspension either 
with protein kinase C (PKC) inhibitors, with synthetic 
peptides or with antibodies for 30-60 min at 37°C; cells 
were then added to fibronectin-coated wells. When cells 
were simultaneously treated with PMA and a PKC in­
hibitor, the incubation with the PKC inhibitor pro­
ceeded by 30 min the PMA treatment and by 45 min the 
addition of cells to FN-coated wells. For the experi­
ments with calphostin C, the incubation was carried 
out for 2 h in an incubator with a fluorescent light 
source to photoactivate calphostin C. Data in adhesion 
assays represent triplicate measurements from at least 
two separate experiments. Adherent cells are expressed 
as the percent of the total cell number in the assay. 
Inhibition of adhesion is expressed as a percentage of 
the control (maximal adhesion).
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Radiolabeling and integrin 
immunoprécipitation experiments
NB4 cells were grown in RPMI with 2% HY. For 125I 
labeling of membrane proteins, 30.106 cells were incu­
bated for 20 min at room temperature with 1 mCi Na 
125I (Amersham) using the iodogen method. They were 
then washed three times and lysed. To measure phos­
phorylation, 30.106 cells were washed three times in 
phosphate-free medium. Cells were resuspended at 
2.106/ml in the same medium with 2% HY and incu­
bated with 1 mCi 32P-orthophosphate (Amersham) for 2
h at 37°C. DMSO (1/104 diluted) or PMA (2.10~7 M)
were added for 20 min at the end of the incubation time. 
Thereafter cells were washed and lysed.
Labeled cells were resuspended in 500 jxl of ice-cold 
lysis buffer containing 10 mM triethanol amine, 150 
mM NaCl, 1% NP40, 5 mM Mg++, 2 mM sodium meta­
vanadate, 1 mM PMSF, 20 |xg/ml leupeptin, 1 mM 
TLCK, 0.2 mM trifluoperazin, 1 |iM microcystin at pH 
7.8, for 45 min at 0~~4°C. Cell lysates were spun down a t 
13,500 rpm for 15 min at 4°C and supernatants were 
precleared by incubating them with 100 fxl of protein 
G-Sepharose precoated with normal mouse serum over­
night at 4°C. The precleared lysates were then incu­
bated with 100 fxl of protein G-Sepharose coated with 
anti-a5 antibody for 2 h at 4°C. Beads were then pel­
leted and washed six times in lysis buffer. Immunopre- 
cipitates were solubilized with 100 fxl of SDS-sample 
buffer for 5 min at 100°C. Samples were electro- 
phoresed on 7.5% SDS-PAGE according to Laemmli 
(1970).
Cell sorter analysis
NB4 cells were pretreated or not with 10~7 M PMA 
for 1 h at 37°C. Cells (2.107/ml) were centrifuged and 
resuspended in PBS with 0.5% BSA, at 4°C. Subsequent 
steps were performed at this temperature; 50 \sA ali­
quots of NB4 suspensions were added to 20 jjlI of MoAbs 
(previously mentioned) in Eppendorf tubes. After a 30- 
min incubation, cells were washed twice with a BSA- 
containing PBS solution, by centrifugation at 2,700 
rpm for 5 min. Cell pellets were resuspended in 100 jjlI  
of a 1/30 dilution of a FITC-labeled goat antimouse 
antibody (Nordic Immunology) and incubated for 30 
min. After two washings, cells were resuspended in 1 
ml PBS and analyzed by flow cytometry on an Ortho 50 
H flow cytometer.
RESULTS AND DISCUSSION 
PMA modulates leukemic cell adhesion to 
marrow stromal cells and ECM
It is well established that hemopoietic progenitors, 
immature myeloblastic or promyelocytic cells are 
tightly associated with marrow stromal cells in the 
marrow as well as to in vitro cultured stromal cells 
(Dexter et al., 1977a; Coulombel et al., 1988, reviewed 
by Storok-Storb, 1988). By contrast, leukemic cells at 
the same stages show marrow egress that could be fa­
voured by loose interactions with stromal cells. In this 
work, using NB4 leukemic cells in an in vitro assay, we 
found that only 10% and 7% of these cells adhered to 
stromal cells and to extracellular matrices, respectively
TABLE 1. NB4 cell adhesion to human marrow stromal cells and 
their ECM1
NB4 adherent cells 
(% of total cpm)
PMA
— +
Stromal cells 10.0 ± 1.5 33.5 ± 2
ECM 7.0 ± 1.5 38.0 ± 2
lRadio-labeled NB4 cells treated or not with PMA (10”7M) were added to stromal cells 
or ECM preparations and allowed to adhere for 2 h at 37°C. Results are expressed as a 
percentage of total cpm in each well. Each value represents the mean of quadruplate 
assays and standard deviations.
(Table 1). We wondered whether these low scores re- 
fleeted some constitutive or functional adhesion de­
fects. PMA, a potent activator of the PKC intracellular 
messenger effector system, added to the NB4 cell cul­
ture rapidly raised the percent adherent cells to 33% on 
stromal cells and 38% on ECM (Table 1). The percent­
ages of adherent cells remained relatively low (no more 
than 38%). This may be explained by the fact that cells 
adhere to a specific substrate, which is the limiting 
parameter in the assay. Indeed, we found that nonad­
herent cells from the first exposure attached to a simi­
lar stromal cell layer in a second assay, with the same 
proportions, thus demonstrating that all PMA-treated 
cells gained the capacity to adhere to microenviron­
mental cells (not shown). These data posed the question 
of the mechanism responsible for PMA-induced leuke­
mic cell adhesion and the biochemical features of the 
receptor-ligand complex which is the ultimate target of 
the PMA signal.
PMA-induced adhesion of leukemic cells to ECM 
is fibronectin-specific and involves the 
activation of PKC
We tested the ability of nontreated or PMA-treated 
cells to adhere to different substrata tha t are known 
components of the ECM: laminin, fibronectin, collagens
I, III, IV, and V. We observed that nontreated cells did 
not adhere to collagens IV and V and presented only a 
weak adhesion to laminin, collagen I, collagen III, and 
fibronectin (Fig. 1). Controls with noncoated or BSA- 
coated plastic surfaces were negative. When cells were 
incubated with PMA, adhesion to FN was enhanced by
5-8-fold when compared to control without PMA. This 
response was restricted to FN: adhesion to other sub­
strata was not enhanced by PMA treatment. NB4 cell 
suspension cultures consisted of spherical, nonadher­
ent cells; 2 h after PMA treatment about 50% of the 
adherent cell population showed cytoplasmic elonga­
tion (pseudopodia). Prolonged incubation in the pres­
ence of PMA (3 h or more) increased this fraction and 
resulted in the spreading of cells on the substrata.
We wondered if other substances acting on the differ­
ent signal transduction pathways could restore a phys­
iological state of adhesion to FN in the same manner as 
PMA. The cAMP elevating agents (CT, IBMX, isopro­
terenol, PGE1 and PGE2) and the cAMP analogs (8- 
CPT-cAMP and 8-Cl-cAMP) did not modify the adhe­
sion of NB4 cells (Table 2). Other prostaglandins such 
as PGFlot, PGF2a, PGAl, and PGD2 were also ineffec­
tive in inducing adhesion. PMA (10-7 M), PDBu (10-6
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Fig. 1. Adhesion of NB4 cells to different substrata, Substrata were 
prepared by coating tissue culture plates for 4 h at 37°C with 2.5 
jxg/well of the indicated proteins and saturating nonspecific binding 
sites with BSA (see Materials and Methods). Cells treated or not with 
PMA (10 ~7 M) were allowed to adhere to the substrata for 2 h at 37°C. 
Cell adhesion was estimated using the spectrophotometric BCA assay.
TA BLE 2. Effects of v a rio u s  com pounds tr ig g e rin g  th e  d ifferen t signal 
tran sd u c tio n  p a th w ay s  on th e  F N -ad h esio n  of NB4 cells
R eag en ts
M o la r i ty 1
(M)
Induction 
of cell adhesion2
cA M P -elevating  a g e n ts
CT 10
IB M X n r 4 —
Isopro terenol 10~s —
PG E 1 10 ” '1 —
PG E2 10 4 —
cAM P analogs 
8-CPT-cAM P IQ “ '1 _
8-Cl-cAM P io - fi —
phorbols
PM A 10~7 + + +
PD B u 1 0 "° + + +
P M A -M ethy l-E ther 2.10""° + + +
Phorbol 2.10~g —
4a~Phorbol 2.10""s — -
’Highestconcentration tested.
2Compared to control without reagent (i.e., 5-15% of adherent cells/ ( - ) :  0-15% ; ( + ): 
15-30%; ( + +  >: 30-70%; C+ + +  ): 70-100%).
M), and PMA-methyl-ether (2.10-6 M) induced an in­
crease in the adhesion of NB4 cells to FN (from 5-15% 
to 70-100% adherent cells). However PMA was the 
most potent phorbol to increase adhesion. Nontumor 
promotor phorbols (phorbol and 4a-phorbol) were inef­
ficient.
NB4 cells were incubated for 30 min with increasing 
doses of PMA (10~10 M to 10~6 M), at 37°C (Fig. 2A). 
Maximal adhesion was obtained with 10~~7 M PMA (90— 
100% of adherent cells). PMA-induced NB4 cell adhe­
sion to FN followed a rapid kinetic. A maximal adhe­
sion was obtained 15 min after addition of PMA 
(Fig. 2B) and persisted for a t least 360 min. Moreover, 
we found (data not shown) th a t a pulse of PMA, fol­
lowed by washing off PMA, was enough to fully induce 
adhesion to FN. It suggests th a t adhesion of NB4 cells 
could account for a direct modification of the adhesion 
effector complex, ra ther than  a transcriptional regula­
tion. Adhesion to FN-coated surface was inhibited by 
blocking the membrane remodeling: adhesion de­
creased by 66% in the presence of 10 mM sodium azide
A
100n
1(T10 10-e 10-7
PMA CONCENTRATION (M)
B
100
t
75-
50
25
° A s  ll5 35 eft 90 l£o 240 360
PMA INCUBATION TIME (Min.)
Fig. 2. Dose-response and kinetic of adhesion of PM A-treated cells to 
fibronectin-coated wells. A. NB4 cells (10(Vml) treated with different 
concentrations of PMA (10“10 M—10-(* M) were allowed to  attach to 
fibronectin-coated plates for 2 h at 37°C. The number of adherent cells 
was determined by the BCA assay (the curve is calibrated using the 
linear correlation between the absorbance at 570 nm and the number 
of attached cells observed in this assay, not shown). B. Plates were 
coated with fibronectin (50 jxg/ml solution). NB4 cells were treated 
with PMA (10“7 M) and added to the wells. Plates were immediately 
centrifuged for 1 min at 1,200 rpm and incubated at 37°C for various 
periods of time (5, 15, 30, 60, 90,120, 240, and 360 min of incubation). 
Reaction was stopped by removing nonattached cells as described in 
Materials and Methods. Adherent cells were measured using the BCA 
assay.
and this was not due to cell death. In addition, the 
induction of adhesion by PMA was blocked when plates 
were incubated at 4°C (not shown). These data sug­
gested an energy-dependent process in adhesion.
As PMA is a potent activator of PKC, we wondered 
whether the induction of adhesion could be inhibited by 
specific PKC inhibitors. Cells were either preincubated 
for 30 min with staurosporine (10~9 M to 10” 6 M) or 
sphingosine (10 “7 M to 10 ”4 M) before addition of PMA 
(10“7 M) or co-incubated with PMA and CGP41251 
(10~10 M to 10~5 M) or calphostin C (5.10~~9 M to 10“G 
M). All these compounds inhibited adhesion in a dose- 
dependent manner (Table 3). CGP 41251 and calphos­
tin C showed higher specificity for PKC compared to 
staurosporine or sphingosine (Meyer et al., 1989; Bruns 
et al., 1991). W7, a specific inhibitor of calmodulin- 
dependent protein kinase did not modulate the NB4 cell 
adhesion to FN. All these compounds had no effect on 
cell viability for the 2-h incubation time, even at the
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TABLE 3. Effects of d iffe ren t p ro te in  k in a se  in h ib ito rs  on th e  
PM A-induced ad hesion  of N B4 cells to F N l
M o la rity % o f in h ib itio n
Inhibitors (M) of ad h es io n IC50 (M)
Staurosporine 10-« 0 1.65.10 7
1CT7 25
i c r fi 90
Sphingosine 10 B 0 6.3 .1 0 -tí
10’ ® 90
CGP41251 10' 0 8 .5 .10"*
i o - 7 54
10-« 87
Calphostin C 2..10”‘8 8 3 .6 .1 0 ~ 7
i o - 7 23
5 .10~ 7 69
W7 1 0 " fi to 5.10 12 0
JCells were cither pveincubated with serial dilutions of mi inhibitory compound (slauro- 
sporine or sphingosine) before the addition of PMA, or sim ultaneously incubated with 
an inhibitory compound (CGP 41251, Calphoslin C or W7) and PMA, Adhesion was  
carried out for 2 h at 37°C.
TABLE 4. NB4 cell su rfac e  expression  of VLA in te g r in  su b u n its  
analyzed by flow c y to m e try 1
Integrin
Monoclonal
antibody
su b u n it
spec ific ity
P ositive  cells 
(% of to ta l)
PM A
— +
K 20 PI 85.5 90.1
GI 9 ix2 2.5 0.2
HP2/1 «4 84.1 88.3
SAM 1 w5 85.0 88.3
GoH 3 ct6 6.3 1.2
'Untreated or PMA-treated cells were incubated with primary monoclonal antibodies 
directed against a specific integrin subunit, then with fluorescein isoLhiocyanato-Ia- 
beled goat antimouse IgG. R esults expressed as percentage of positive cells are represen­
tative values From two separate experiments.
highest doses tested. These results strongly suggested 
that the effects of PMA were mediated by protein k i­
nase C activation.
VLA-5 specific FN-receptors are involved in 
PMA-induced leukemic cell adhesion
PMA-induced adhesion was also blocked when cells 
were incubated in medium with 1 mM EDTA (94% inhi­
bition, not shown). This result supported the idea of a 
divalent cation-dependent mechanism resembling inte- 
grin-mediated adhesion. We examined the possibility of 
involvement of VLA-integrin receptors in PMA-in- 
duced adhesion. One hypothesis would be th a t PMA 
changes the expression pattern of receptors involved in 
recognition of ECM components and especially FN as it 
has been described for U937 cells (Ferreira et al., 1991). 
The expression of CD29, CDw49b, CDw49d, Cw49e, 
and CDw49f molecules, which correspond to (31, a2, a4, 
a5, and a 6 chains of integrins, was analyzed. CD29, 
CDw49d, and CDw49e (pi, a4, and a5) were found to be 
expressed on NB4- cells (Table 4); other antigens (a2 
and a 6) were not detected. The results showed th a t 
a4(31 (VLA-4) and a5 p l (VLA-5) receptors are constitu- 
tively expressed on NB4 cells and th a t PMA did not 
modulate either the percentage of positive cells or the 
level of membrane expression of these integrins 
(Fig. 3). The absence of expression of other integrins 
(a2(31, a 6pl) persists after PMA treatm ent. This sug­
gests that PMA-induced adhesion could be explained
rather by a structural modification and/or activation of 
a FN-specific integrin receptor, than  by an increase in 
its membrane expression.
We determined whether the expressed receptors 
(a4pl and a5pl) were involved in PMA-induced adhe­
sion. Gi9 (anti-a2) and HP2/1 (anti-a4) MoAbs did not 
affect NB4 adhesion to FN (Fig. 4). A slight inhibitory 
effect (13% inhibition) was observed with GoH3 (anti­
cs) MoAb. By contrast, AIIB2 (anti-pi) MoAb and 
SAMI (anti-a5) MoAbs inhibited attachm ent of NB4 
cells to FN (87% and 80% inhibition, respectively). This 
inhibitory effect was not significantly increased (90%) 
when the an ti-p i MoAb was simultaneously added to 
the anti-a5 MoAb. These results support the conclusion 
th a t adhesion of NB4 cells to FN observed after PMA 
treatm ent was mediated by the receptor c*5pl (VLA-5) 
and th a t the other FN-specific receptor VLA-4 was not 
involved in this interaction. The prim ary cell binding 
site of FN has been assigned to the sequence Arg-Gly- 
Asp (RGD) localized within the central binding domain 
of the molecule and is recognized with high affinity by 
the a5 p i integrin (Hynes, 1987; Ruoslahti, 1987). Com­
petition experiments demonstrated tha t the synthetic 
RGDS peptide inhibited NB4 cells adhesion to FN with 
an ID50 of ~  5.8 mM (Fig. 5). The control peptide RGES 
did not prevent cell adhesion. It confirmed that PMA- 
induced adhesion to FN is mediated by the a5 p i inte­
grin, a conclusion th a t is in agreement with previous 
work showing th a t VLA-5 is a specific FN-receptor in­
volving the RGD site in a number of cell systems (Ruo- 
slahti and Pieerschbacher, 1987; Ruoslahti et al.,
1988).
PKC-dependent activation of ceSpi receptor is 
not due to its phosphorylation
Considering the kinetic of response to PMA (Fig. 2B), 
it  was unlikely th a t PMA acted a t the gene transcrip­
tion level to promote adhesion, as it  has already been 
described in other cell systems (Goldstein et al., 1990). 
Cell sorter analyses proved th a t adhesion did not result 
from a modulation of the expression of integrin recep­
tors a t the membrane surface (de novo synthesis or 
redistribution of cryptic receptors). The activation of an 
integrin-receptor complex constitutively expressed at 
the cell surface, as already described in other hemopoi­
etic cells (Symington et al., 1989; Ylanne et a lM 1990; 
Van Kooyk et al., 1991), seems more likely. We ques­
tioned whether stimulation of PKC byPMA resulted in 
an altered pattern  of phosphorylation of the a5p i recep­
tor. A modulation of phosphorylation of integrins (p2 
integrins or a 6pl) induced by PMA treatm ent has al­
ready been observed in mononuclear cells and in mac­
rophages by Chatila et al. (1989) and Shaw et al. (1990). 
As seen in Figure 6, two bands were observed after 
immunoprecipitation of iodinated cells, corresponding 
to the a5 chain (160 kDa) and the p i  chain (135 kDa) of 
the receptor but none of them were constitutively phos- 
phorylated in NB4 cells and PMA treatm ent did not 
induce their phosphorylation. To definitively exclude 
the possibility of phosphatase activity in lysates, the 
highly potent phosphatase inhibitor microcyst in (1 jxM) 
was added to the panel of phosphatase inhibitors classi­
cally used (see methods). In conclusion, VLA-5 seems to 
be a very poor substrate for PKC since no phosphoryla-
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Fig. 3* Flow cytometry analysis of the expression of (51, a4, and «5 integrin subunits on NB4 cell surface 
treated or not with PMA. NB4 cells were incubated for 30 min at 4°C with a primary antibody (K20, HP2/1 
or SAMI), washed twice, then labeled with a FITC-conjugated goat antimouse Ig G for 30 min at 30°C.
tion was detected, and thus confirmed the observation 
made by Danilov and Juliano (1990).
These experiments show th a t PMA modulation of ad­
hesion probably does not involve phosphorylation of the 
receptor itself. PKC-dependent adhesion could involve 
the phosphorylation of other cellular proteins tha t in­
teract directly (cytoskeletal proteins) or indirectly with 
the FN receptor complex during the adhesion process. 
Previous reports, in other biological systems, suggest a 
regulation of (31 integrin function by modification of 
molecular avidity (Neugebauer and Reichardt, 1991) in 
relation to conformational changes. Components of cell 
membrane associated to integrins, like lipids (ganglio- 
side GD3 for a5(31 (Stallcup et al., 1989); IMF-1 lipid 
(Wright et al., 1990, 1992) for complement receptor 
type 3 (Wright et al., 1989), could also participate in 
transient allosteric changes sufficient to explain in­
creased functional activity. Ferreira et al. (1991) 
showed th a t FN receptors of PMA treated U937 cells
had different molecular masses than those of resting 
cells. Differences in FN receptor sialylation have also 
been described in K562 leukemic cells after PMA treat­
ment (Van de Water et al., 1988; Symington et al, 
1989). It is unlikely that such glycosylation or sialyla­
tion changes are involved in the NB4 adhesion to FN 
since PMA treatm ent of NB4 cells is short (2 h) com­
pared to PMA exposure (at least 38 h) in the cases of 
U937 or K562 cells. Other mechanisms of regulation of 
VLA-5 activation such as protein dephosphorylation or 
intracellular calcium changes are not excluded.
CONCLUSIONS
Numerous reports have suggested tha t integrins are 
involved in cell migration and metastatic tumor inva­
sion (Liotta, 1986). Moreover, the increased or de­
creased expression of integrins was found associated to 
the enhanced capacity of cells to become tumorigenic. 
In the hematopoietic system, the adhesive capacity of
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Fig. 4. Inhibition of PMA-treated NB4 cells adhesion to fibronectin 
by anti-integrin MoAbs. PMA-treated cells were preincubated for 30 
min at 37°C with the following MoAbs (1/100 dilution) before their  
addition to fibronectin~coated wells: AIIB2 (anti-(31 chain), GI9 
(anti-«2 chain), HP2/1 (anti-a4 chain), SAMI (anti-a5 chain), and 
GoH3 (anti-cx6 chain). Results are expressed as a percentage of adher­
ent cells in controls {wells without MoAbs).
progenitor cells regulates proliferation and differentia­
tion (Torok-Storb, 1988) and influences the response to 
growth factors (Gordon, 1988). Abnormal response to 
growth factors and m aturation defects are features of 
leukemia generally associated to undue egress of im­
mature cells from the marrow. In this work, we show 
that PKC activation can restore a physiological state of 
adhesion of promyelocytic cells to stromal cells or their 
ECM through a specific RGD-dependent binding to FN, 
This interaction resulted from a PKC driven intracellu­
lar mechanism th a t operated on the VLA-5 specific FN 
receptor. The increase in adhesion does not result from 
a modulation of the expression of VLA-5 receptors at 
the membrane surface or from an activation of th is 
receptor consequent to its phosphorylation. In this 
work, we have defined a promising model to study the 
synergistic effects of FN-dependent adhesion and 
growth factor or m aturation inducer signals on leuke­
mic cell differentiation.
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